OVERVIEW: Concern awards grants for early career investigators studying cancer immunology, genetics, and cell biology. The foundation awards around 20 grants per year.
IP TAKE: Concern is an approachable funder that accepts unsolicited grant applications. The foundation tends to back research that takes a “strong hypothesis-driven approach,” that is both original and potentially significant to the field of cancer research.
PROFILE: The Concern Foundation was founded by 15 couples who collectively decided to fund cancer research right off the bat. In those early days, the foundation supported Dr. David Weiss’ research at the Lautenberg Center for Tumor Immunology at the Hebrew University of Jerusalem. Dr. Weiss’ research would later be accepted for evaluation by the National Institutes of Health.
Since then, Concern’s research grant funding has grown to support around 20 investigators each year who are studying cancer immunology, genetics, and cell biology. The Conquer Cancer Now Award is reserved for early career researchers who have achieved the professional level of assistant professor or its equivalent and who “have yet to obtain significant funding for their work.”
Grant amounts are $60,000 per year for up to two years. The foundation notes that while the second year of funding is possible, it is not guaranteed and is dependent upon progress, funds available, and approval from the foundation’s board. Grants are awarded in quarterly installments.
To get a broader sense of the type of research supported by Concern, explore its Meet Our Researchers page, which provides detailed information on researchers and their work.
Grantees are chosen by Concern’s Scientific Review Committee, which is composed of research scientists from organizations across the U.S. and abroad. The foundation accepts unsolicited grant applications every other year from institutions in the United States and abroad, noting that prospective grantees are not required to have U.S. citizenship to be eligible for a grant. Letters of Intent may be submitted here.